These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3142824)

  • 21. Acute intervention in myocardial infarction--role of thrombolytic therapy and adjuvant angioplasty.
    Joseph A; Talley JD; Kupersmith J
    J Ky Med Assoc; 1988 Oct; 86(10):561-6. PubMed ID: 2976079
    [No Abstract]   [Full Text] [Related]  

  • 22. t-PA therapy in acute myocardial infarction.
    Giebel RA; Pavey SS; Bryant PP
    J Emerg Nurs; 1988; 14(4):206-13. PubMed ID: 3137387
    [No Abstract]   [Full Text] [Related]  

  • 23. Formulating appropriate nursing diagnoses for the patient receiving tissue-type plasminogen activator.
    Brooks-Brunn JA
    Heart Lung; 1987 Nov; 16(6 Pt 2):787-91. PubMed ID: 3119523
    [No Abstract]   [Full Text] [Related]  

  • 24. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
    DePorto R; Ahn JH; Gianutsos JG
    J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding secondary to the use of thrombolytic agent in a patient with recent renal lithotripsy.
    Bleckley JE; Morse HG
    J S C Med Assoc; 1991 Nov; 87(11):549-50. PubMed ID: 1766245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.
    Califf RM; Topol EJ; George BS; Boswick JM; Abbottsmith C; Sigmon KN; Candela R; Masek R; Kereiakes D; O'Neill WW
    Am J Med; 1988 Sep; 85(3):353-9. PubMed ID: 3137818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenic hemorrhage after tissue plasminogen activator for acute myocardial infarction.
    Blankenship J; Indeck M
    N Engl J Med; 1991 Sep; 325(13):969. PubMed ID: 1908949
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there a new i.v. push t-PA?
    Sweeney E
    Heartbeat; 1990; 1(3):3. PubMed ID: 2127727
    [No Abstract]   [Full Text] [Related]  

  • 29. Markers of reperfusion after thrombolytic therapy for acute myocardial infarction.
    Lieberman KS
    J Emerg Nurs; 1995 Apr; 21(2):112-5. PubMed ID: 7776600
    [No Abstract]   [Full Text] [Related]  

  • 30. Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward.
    Vaughan DE; Braunwald E
    J Am Coll Cardiol; 1992 Apr; 19(5):1076-8. PubMed ID: 1552098
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of serum total cholesterol on hemorrhagic complications following thrombolytic therapy for acute myocardial infarction.
    Caputo R; Corrao JM; Lew R; Becker RC
    Cardiology; 1991; 79(3):211-8. PubMed ID: 1769036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction.
    Arora RR; Magun AM; Grossman M; Katz J
    Am Heart J; 1993 Jul; 126(1):225-8. PubMed ID: 8322670
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac tamponade following treatment with tissue plasminogen activator: an atypical hemodynamic response to pericardiocentesis.
    Barrington WW; Smith JE; Himmelstein SI
    Am Heart J; 1991 Apr; 121(4 Pt 1):1227-9. PubMed ID: 1901191
    [No Abstract]   [Full Text] [Related]  

  • 34. Toward achieving optimal reperfusion: revisiting thrombolysis.
    Becker RC
    Coron Artery Dis; 1994 Aug; 5(8):717-22. PubMed ID: 8000626
    [No Abstract]   [Full Text] [Related]  

  • 35. A 40-year-old patient with an evolving extensive inferior MI treated with t-PA thrombolytic therapy.
    Denke NJ
    J Emerg Nurs; 1988; 14(6):334-7. PubMed ID: 3144621
    [No Abstract]   [Full Text] [Related]  

  • 36. Parapharyngeal hemorrhage secondary to thrombolytic therapy for acute myocardial infarction.
    Scuba JR; Parrado C
    J Oral Maxillofac Surg; 1992 Apr; 50(4):413-5. PubMed ID: 1545300
    [No Abstract]   [Full Text] [Related]  

  • 37. Offshore innovation.
    Carlson E
    JEMS; 2006 Jan; 31(1):28. PubMed ID: 16423644
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic therapy orders and record sheets: nursing care made easier.
    Rafter RH
    J Emerg Nurs; 1988; 14(4):237-9. PubMed ID: 3137388
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetes.
    Grekos ZG; Schocken DD
    Am Heart J; 1995 Sep; 130(3 Pt 1):611-2. PubMed ID: 7661080
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous hepatic hemorrhage following treatment with tissue plasminogen activator.
    Roongsritong C; Buell JC
    Int J Cardiol; 1994 Sep; 46(2):182. PubMed ID: 7814170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.